Peter Llewellyn-Davies

Peter Llewellyn-Davies

Director/Board Member chez SHIELD THERAPEUTICS PLC

Fortune : 4 549 $ au 31/03/2024

66 ans
Health Technology
Commercial Services
Finance

Profil

Peter Llewellyn-Davies is the founder of Acceleration Partners LLC.
He currently holds the position of Chief Executive Officer at invIOs Holding AG, Chairman-Management Board at Biotechnologie-Industrie-Organisation Austria, Independent Non-Executive Director at Shield Therapeutics Plc, and Chief Executive & Financial Officer at APEIRON Biologics AG.
Previously, he held positions such as Executive Director-Finance at Süd-Chemie AG, Managing Director at Müller Dairy (UK) Ltd., Director at Catherex, Inc., Chief Financial Officer & Executive Director at Wilex, Inc., Non-Executive Director at Immunocore Holdings Plc, Member-Supervisory Board at 2invest AG, Chief Financial Officer at CoreOptics GmbH, Chief Financial & Business Officer at MediGene AG, and Chief Financial Officer at Heidelberg Pharma AG.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
31/12/2022 177 842 ( 0,02% ) 4 549 $ 31/03/2024

Postes actifs de Peter Llewellyn-Davies

SociétésPosteDébut
SHIELD THERAPEUTICS PLC Director/Board Member 01/02/2016
Chief Executive Officer 15/07/2018
invIOs Holding AG Chief Executive Officer 01/12/2021
Biotechnologie-Industrie-Organisation Austria Chief Executive Officer 01/12/2020
Tous les postes actifs de Peter Llewellyn-Davies

Anciens postes connus de Peter Llewellyn-Davies

SociétésPosteFin
2INVEST AG Director/Board Member 28/01/2021
MEDIGENE AG Director of Finance/CFO 31/03/2016
HEIDELBERG PHARMA AG Director of Finance/CFO 10/10/2012
Founder -
Director of Finance/CFO -
Voir l'expérience en détail de Peter Llewellyn-Davies

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Peter Llewellyn-Davies

Relations

68

Relations au 1er degré

14

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées5
2INVEST AG

Finance

MEDIGENE AG

Health Technology

HEIDELBERG PHARMA AG

Health Technology

SHIELD THERAPEUTICS PLC

Health Technology

IMMUNOCORE HOLDINGS PLC

Health Technology

Entreprise privées9

Electronic Technology

Process Industries

Consumer Non-Durables

Health Technology

Commercial Services

Health Services

Commercial Services

invIOs Holding AG

Biotechnologie-Industrie-Organisation Austria

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Peter Llewellyn-Davies